TrialCancer immunology, immunotherapy : CII2016

A randomized pilot trial testing the safety and immunologic effects of a MAGE-A3 protein plus AS15 immunostimulant administered into muscle or into dermal/subcutaneous sites.

Craig L Slingluff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.